Can You Advertise ADHD Telehealth on Meta and Google?

What this means for you

• On Meta, ADHD evaluation and care ads run without authorization. Naming a stimulant or any prescription medication needs active LegitScript certification and Meta's authorization, 18+, in the US, Canada or New Zealand.
• On Google, an ADHD telehealth service that prescribes is a prescription drug service. It needs LegitScript Healthcare Merchant Certification and Google's own certification before ads serve.
• Stimulants such as amphetamine, methylphenidate and lisdexamfetamine are Schedule II. Prescribing them by telemedicine without an in-person evaluation relies on DEA flexibilities that run through December 31, 2026.
• "Can't focus?" implies a condition and fails on Meta. On Google, health is a sensitive category, so remarketing and customer lists are off.
• The FDA requires a boxed warning on every prescription stimulant for misuse, abuse, addiction and overdose. Ads that make a prescription sound quick or easy work against that.

MedScale Health, a paid acquisition agency for telehealth brands and clinics, plans Meta and Google campaigns for telehealth mental health programs, including ADHD evaluation and care. ADHD is where platform rules, federal drug scheduling and a dated DEA rule meet, so this page takes them in that order. This page is marketing guidance, not medical or legal advice. Platform policies change, so check the sources listed at the end before acting on a specific rule.

Meta: the service runs, the stimulant needs authorization

Meta's Drugs and Pharmaceuticals policy says advertisers don't need written authorization to run ads that promote telehealth services generally. An ad for an ADHD evaluation with a licensed clinician, ongoing care and a clear price is a telehealth service ad. An ad that names a stimulant, shows a prescription bottle or promises medication is a prescription drug ad, and Meta then requires active LegitScript certification, Meta's authorization, a disclaimer to consult a licensed health professional or obtain a valid prescription, and targeting limited to people 18 and over in the United States, Canada or New Zealand where the advertiser is certified.

The same policy bars ads that encourage the consumption of potentially unsafe drugs. Stimulants carry a known misuse risk, so speed-to-prescription hooks such as "meds in days" are the first ads to drop.

Meta: the copy and the pixel

Meta's personal attributes policy bars ads that assert or imply a viewer's physical or mental health. "Depression counseling" is Meta's own passing example, and "Depression getting you down? Get help now." its failing one. ADHD follows the same pattern: "Can't focus at work?" and "Always losing your keys?" imply a condition, and "ADHD evaluations with licensed clinicians, online" does not.

Meta's Business Help Center lists mental health and psychological states, prescription medications and medical testing among the information advertisers must not share through its business tools, and says event names and custom audiences must not reflect it. An event called adhd_assessment_complete does exactly that. MedScale tracks server-side under a BAA with neutral event names, and no names, emails, phone numbers, IP addresses or browser IDs go to any ad platform.

Google: certification comes first for telehealth

Google restricts the promotion of services related to the online prescribing, dispensing and sale of prescription drugs, and names telemedicine providers among the businesses covered. It judges scope from the ads, the site and the services offered, and errs on the side of caution with landing pages that appear to facilitate online prescribing. An online ADHD evaluation that can end in a prescription is in scope. In the US, Google allows telemedicine providers accredited through LegitScript's Healthcare Merchant Certification Program, and the advertiser must also be certified by Google.

Drug names follow the restricted drug terms policy. In the US, prescription drug terms can appear in ads and landing pages without certification, but keyword-targeting them needs certification, and telemedicine providers need certification regardless. The policy points to a non-exhaustive list of monitored prescription drugs, which includes methylphenidate, lisdexamfetamine and dextroamphetamine, and brand names such as Adderall, Ritalin and Vyvanse.

Google's personalized advertising policy treats physical and mental health conditions as a sensitive category, and prescription medications as another. Customer match, your data segments, audience expansion and lookalike segments are off. Predefined audiences remain, and nobody under 18 sees personalized ads. An ADHD account runs on search intent and location.

The DEA date under every ad

Stimulants used for ADHD, including amphetamine, methylphenidate and lisdexamfetamine, are Schedule II controlled substances (21 CFR 1308.12). Under the Ryan Haight Act, dispensing controlled substances over the internet generally requires a prescription based on at least one in-person medical evaluation. The DEA's temporary telemedicine flexibilities lift that requirement for now, and the fourth extension, Federal Register document 2025-24123, keeps them in effect from January 1 through December 31, 2026. The DEA says the extension gives it time to finalise permanent rules.

For advertising, that date is a planning fact. Ads and landing pages that promise care with no in-person visit ever should be written so they still hold if the rules change. Lead with the evaluation and the clinician, say a licensed provider decides whether medication is appropriate, and keep the remote-only promise out of the headline.

The FDA's stimulant warning

On May 11, 2023 the FDA required updates to the boxed warning, its most prominent warning, for all prescription stimulants, so that every label in the class describes the risks of misuse, abuse, addiction and overdose consistently. It also added that patients should never share their prescription stimulants with anyone. Ad copy should sit comfortably next to that warning: clinical and plain, never urgent or easy.

What still gets rejected

• Stimulant names, prices or bottles in Meta ads before LegitScript certification and Meta's authorization.
• Google ads for an online ADHD service that prescribes, before LegitScript and Google certification.
• Hooks about focus, forgetfulness or restlessness aimed at the reader.
• Speed and ease promises about getting medication.
• Remarketing lists, customer match and condition-named pixel events.

What MedScale does

MedScale Health builds ADHD telehealth accounts evaluation-first: Meta campaigns about the clinicians, the evaluation and ongoing care that can run now; landing pages that say a licensed provider decides whether medication is appropriate; server-side tracking with neutral event names; and LegitScript certification help with the Meta authorization and Google certification applications where the model needs them. No approval or result is guaranteed. Start with the free growth audit at medscale.health/audit.